Miglustat HCl

Overview

Miglustat HCl is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1). It also inhibits glucosidase I and II, as well as HIV-1 and HIV-2 infection of peripheral blood mononuclear cells (PBMCs). Source summary: Order Miglustat HCl for advanced glycosphingolipid research; supplied with high purity for laboratory use. Buy now to enhance your biochemical studies.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Glucosylceramide Synthase

Product Information

• Catalog No.: B0084-101894
• CAS No.: 210110-90-0
• Molecular Formula: C10H21NO4HCl
• Molecular Weight: 255.74
• Purity: 98%

Source

Original product source